FDA approvals in 2023: biomarker-positive subsets, equipoise and verification of benefit
Crossref DOI link: https://doi.org/10.1038/s41571-024-00871-5
Published Online: 2024-02-21
Published Print: 2024-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Norsworthy, Kelly J.
Lee-Alonzo, Rosa J. http://orcid.org/0009-0007-9823-599X
Pazdur, Richard http://orcid.org/0000-0002-4771-9923
Text and Data Mining valid from 2024-02-21
Version of Record valid from 2024-02-21
Article History
First Online: 21 February 2024
Competing interests
: The authors declare no competing interests.